Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review
ConclusionLimited information is available from placebo-controlled RCTs on the efficacy (by ADHD-RS-IV) or safety of medication in children with ADHD and psychiatric comorbidities. Further studies are required to support evidence-based drug selection for these populations.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: ADHD | Anxiety | Autism | Brain | Children | Concerta | Depression | Generalized Anxiety Disorder (GAD) | Hyperactivity | Methylphenidate | Neurology | Psychiatry | Ritalin | Strattera | Study | Tourette Syndrome